Status:
COMPLETED
A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
Lead Sponsor:
Novartis
Conditions:
Primary Hypertension
Eligibility:
All Genders
21+ years
Phase:
PHASE4
Brief Summary
This study is to assess the efficacy of the fixed combination of Valsartan and Amlodipine in hypertensive patients uncontrolled by monotherapy.
Eligibility Criteria
Inclusion
- Patient uncontrolled by mono-therapy for at least 8 weeks, having B.P.\>/= 140/90 mmHg in non diabetics or \>/= 130/80 mmHg in diabetics
Exclusion
- Patient having B.P.\>= 180/110 mmHg in non diabetics or \>= 160/100 mmHg in diabetics
- Type 1 Diabetes or uncontrolled type 2 Diabetes.
- PCI in last 12 months.
- Concomitant unstable angina. Other protocol-defined inclusion/exclusion criteria may apply
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01241487
Start Date
February 1 2009
End Date
January 1 2011
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Ahmed Anwar Clinic,
Cairo, Egypt